# Evaluation of BIS for Quantification of Lymphedema

> **NCT01544335** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 270 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Bioimpedance Spectroscopy

## Key facts

- **NCT ID:** NCT01544335
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01544335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01544335, "Evaluation of BIS for Quantification of Lymphedema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01544335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*